Health Canada is recommending against administering the Oxford-AstraZeneca vaccine to people under 55 following new reports of patients developing blood clots in Europe.
CANADA - Health Canada is recommending the provinces and territories suspend use of the Oxford-AstraZeneca COVID-19 vaccine for people under the age of 55.
This is following new reports of patients in Europe developing blood clots. Most of them were women under 55 and the fatality rate is as high as 40 percent.
Health Canada would like the drugmaker to conduct a detailed study on the risks and benefits of the vaccine across multiple age groups.
The National Committee on Immunizations is also recommending against administering the shot to anyone under 55. It has no plans to rescind it's overall approval of the vaccine at this time.

PJHL Recap - Oct 30th to Nov 1st
Navy Vets Recap - Nov 1st
United Way Burger Battle Begins!
Oxford County Releases Survey Results
Cheese and Cheers Coming to Woodstock
PJHL Preview - Oct 30th to Nov 1st
Daylight Saving Time Ends Sunday
Halloween Safety Tips from WPS
Patrick Stewart Dead at 86
SWOX Crash Results in Minor Injuries
UPDATE: Deceased Identified in Homicide Investigation
Interview with the Warden - October 29th, 2026
News Poll: Oxford County Municipal Election Results
Milwaukee Brewers Win the World Series
Great Pumpkin Rescue Returns for 2026
Oxford County Continues Watermain Flushing
Poppy Campaign Underway in Oxford
Norfolk OPP Briefs - October 28th, 2026
Comments
Add a comment